Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2012, Vol 1, Issue 1
Abstract
Need for Pharmacogenomic Information Also for Generic Medications; Recommendation of the European Society of Pharmacogenomics and Theranostics (ESPT)
Authors and Affiliations
Gerard Siest
Keywords
Related Articles
- EP ID EP201576
- DOI 10.19070/2167- 910X-120002e
- Views 84
- Downloads 0
PAR-2-Mediated Relaxation of Rectum is Impaired Following Bacillary Dysentery in Rat
Background: PAR-2 activation modifies the intestinal motility and takes part in gastrointestinal motility disturbances under intestinal infection or inflammation, but its role in the regulation of normal rectum motility...
Steady State Plasma Levels of Bupropion After Administration of 3x150 Mg Extended Release Reference Tablets and Switching to 1x450 Mg Extended Release 450ER Tablets
In order to provide patients who take 450 mg/day bupropion hydrochloride for the treatment of severe depressive disorder with a safe and convenient alternative to currently existing dose regimens, a high-dose bupropion E...
Effect of Some Anti hypertensive Drugs on Alkaline Phosphatase and DNA of Mice
The dislipidemias are a risk factor well recognized of the cardiovascular diseases and constitute a problem of public health. A descriptive study in 150 patient elders of 30 years with diagnosis of Izquemic Cardiopathyes...
Liquid-Liquid Extraction vs Solid Phase Extraction in Biological Fluids and Drugs
Liquid-Liquid Extraction vs Solid Phase Extraction in Biological Fluids and Drugs
PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review
Cardiovascular diseases are major contributors of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM), while dyslipidemia and hyperglycemia are key modifiable risk factors to prevent coronary artery...